- Keywords
- TERAZOSIN,
- MeSH
- Adrenergic alpha-1 Receptor Antagonists economics MeSH
- Anti-Infective Agents economics MeSH
- Doxazosin economics MeSH
- Gastrointestinal Agents economics MeSH
- Nucleic Acid Synthesis Inhibitors economics MeSH
- Drug Prescriptions * standards MeSH
- Humans MeSH
- Drug Costs MeSH
- Rifaximin MeSH
- Urological Agents economics MeSH
- Check Tag
- Humans MeSH
- MeSH
- Diagnostic Errors MeSH
- Adult MeSH
- Cardiovascular Agents adverse effects MeSH
- Humans MeSH
- Anorexia MeSH
- Drug-Related Side Effects and Adverse Reactions MeSH
- Polypharmacy * MeSH
- Psychotropic Drugs adverse effects MeSH
- Aged, 80 and over MeSH
- Inappropriate ADH Syndrome etiology MeSH
- Syncope etiology MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Female MeSH
- Publication type
- Case Reports MeSH
- MeSH
- Anti-Bacterial Agents MeSH
- Anticoagulants MeSH
- Antithrombins MeSH
- Calcium Channel Blockers metabolism adverse effects therapeutic use MeSH
- Dabigatran administration & dosage adverse effects MeSH
- Clarithromycin * metabolism therapeutic use MeSH
- Drug Interactions * MeSH
- Humans MeSH
- Macrolides MeSH
- ATP Binding Cassette Transporter, Subfamily B, Member 1 antagonists & inhibitors adverse effects therapeutic use MeSH
- Risk Factors MeSH
- Arrhythmias, Cardiac chemically induced MeSH
- Heart Rate drug effects MeSH
- Hydroxymethylglutaryl-CoA Reductase Inhibitors metabolism adverse effects MeSH
- Long QT Syndrome etiology physiopathology MeSH
- Warfarin adverse effects MeSH
- Check Tag
- Humans MeSH
- Publication type
- Review MeSH
Práce předkládá stručný přehled lékových interakcí založený na mechanismech jejich vzniku. Tabelárně jsou zpracovány farmakokinetické lékové interakce s rozlišením jejich klinického významu. Jsou uvedeny inhibitory a induktory CYP3A4 a P-glykoproteinu dle síly jejich působení.
Authors present a brief overview of drug interactions based on the mechanisms of their origin. Tabular are processed pharmacokinetic drug interactions with the resolution of their clinical significance. They are listed inhibitors and inducers of CYP3A4 and P-glycoprotein according to the strength of their action.
- MeSH
- Anti-Asthmatic Agents * adverse effects therapeutic use MeSH
- Asthma drug therapy MeSH
- Pulmonary Disease, Chronic Obstructive drug therapy MeSH
- Cytochrome P-450 CYP3A Inhibitors pharmacokinetics adverse effects therapeutic use MeSH
- Drug Interactions * MeSH
- Humans MeSH
- Check Tag
- Humans MeSH
- Publication type
- Review MeSH
- MeSH
- Candida albicans MeSH
- Economics, Pharmaceutical MeSH
- Fluconazole administration & dosage therapeutic use MeSH
- Clinical Competence MeSH
- Drug Prescriptions * economics standards MeSH
- Humans MeSH
- Medication Errors MeSH
- Drug Costs MeSH
- Otitis Media drug therapy MeSH
- Primary Health Care organization & administration MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Case Reports MeSH
- Keywords
- ENYGSTOL,
- MeSH
- Acetylcysteine * therapeutic use MeSH
- Antidepressive Agents, Tricyclic therapeutic use MeSH
- Cilostazol MeSH
- Glucagon therapeutic use MeSH
- Injections MeSH
- Drug Prescriptions * standards MeSH
- Humans MeSH
- Mianserin * therapeutic use MeSH
- Piperidines therapeutic use MeSH
- Tetrazoles therapeutic use MeSH
- Check Tag
- Humans MeSH
- MeSH
- Drug Interactions MeSH
- Drug Prescriptions * MeSH
- Humans MeSH
- Education * MeSH
- Check Tag
- Humans MeSH